Treatment options for newly diagnosed patients with adult acute lymphoblastic leukemia Journal Article


Authors: Lamanna, N.; Weiss, M.
Article Title: Treatment options for newly diagnosed patients with adult acute lymphoblastic leukemia
Abstract: The treatment of adults with acute lymphoblastic leukemia (ALL) has been modeled on therapy developed for childhood ALL. The similarity between childhood and adult forms of this disease allows for inferences to be drawn from experience in the pediatric population. However, adults with ALL have far poorer outcome when compared to children. Some of this difference can be attributed in ability to tolerate intensive therapy coupled with an increased incidence of unfavorable cytogenetic subgroups and a decreased incidence of favorable cytogenetic subgroups. Treatment of adult ALL is typically divided into four broad categories: induction, consolidation, maintenance, and central nervous system prophylaxis. Despite three decades of clinical investigation for devising improved treatment programs for adults with ALL, no single program has emerged as the standard. Here we review classification, prognostic features, current treatment programs, and new advances as applied to adult patients with newly diagnosed ALL.
Keywords: adult; treatment outcome; clinical trial; review; multimodality cancer therapy; combined modality therapy; antineoplastic agent; classification; antineoplastic combined chemotherapy protocols; pathology; skull irradiation; cranial irradiation; cancer invasion; meninges; remission; remission induction; acute lymphocytic leukemia; bone marrow transplantation; clinical trials; meninx; leukemic infiltration; humans; prognosis; human; leukemia, lymphocytic, acute, l2
Journal Title: Current Hematology Reports
Volume: 3
Issue: 1
ISSN: 1540-3408
Publisher: Current Science Inc.  
Date Published: 2004-01-01
Start Page: 40
End Page: 46
Language: English
PROVIDER: scopus
PUBMED: 14695849
DOI/URL:
Notes: Curr Hematol Rep -- Cited By (since 1996):6 -- Export Date: 16 June 2014 -- Source: Scopus
Citation Impact
MSK Authors
  1. Nicole Lamanna
    60 Lamanna
  2. Mark Weiss
    86 Weiss